Portrait image of Carlos Ciller

Dr. Carlos Ciller is CEO and co-founder of RetinAI, a Swiss startup developing software to accelerate and support clinical and pharmaceutical research workflows. He holds a degree in Telecommunications Engineering and a PhD in Machine Learning and Medical Imaging in Ophthalmology from the University of Lausanne (CHUV-CIBM), the EPFL and the University of Bern in Switzerland. Between 2015-2016 he was a visiting researcher at the Biomedical Image Analysis group, at the Department of Computing of Imperial College London, UK, as a recipient of a Swiss grant for PhD Mobility.

Prior to his PhD, Carlos worked for several years as a research engineer and project manager in healthcare projects. He was president of Innovation Forum Imperial College London and member of the Board of Directors of multiple for and non-for profit organisations. Carlos is author and co-author of dozens of conference papers, book chapters and peer-reviewed journals in the field of artificial intelligence, machine learning, medical imaging and ophthalmology.

AMLD EPFL 2022 / Speakers

Michael Bronstein

Oxford / Twitter / IDSIA

Max Welling

Distinguished Scientist, Microsoft Research

Samy Bengio

Senior Director, AI and Machine Learning Research, Apple

Regina Barzilay

Professor of Electrical Engineering and Computer Science, MIT

Melanie Mitchell

Davis Professor, Santa Fe Institute

Thomas Wolf

Co-founder and Chief Science Officer, Hugging Face

AMLD / Global partners